ChemicalBook >> CAS DataBase List >>oleandomycin

oleandomycin

CAS No.
3922-90-5
Chemical Name:
oleandomycin
Synonyms
C01946;PA 775;PA-105;Romicil;Amimycin;Landomycin;oleandomycin;OleandoMycin A;Antibiotic PA-105;AMiMycin, MatroMycin, PA 105
CBNumber:
CB5928730
Molecular Formula:
C35H61NO12
Molecular Weight:
687.86
MDL Number:
MFCD00242812
MOL File:
3922-90-5.mol
MSDS File:
SDS
Last updated:2023-05-18 11:31:11

oleandomycin Properties

Melting point 110 °C (decomp)
Boiling point 802.6±65.0 °C(Predicted)
Density 1.21±0.1 g/cm3(Predicted)
storage temp. -20°C Freezer
solubility DMSO (Slightly), Methanol (Slightly)
form Solid
pka pKa 8.84(H2O,t =25,I=0.167) (Uncertain)
color White to Off-White
EWG's Food Scores 1
FDA UNII P8ZQ646136
ATC code J01FA05

SAFETY

Risk and Safety Statements

Toxicity LD50 orl-rat: 6700 mg/kg AMPMAR 39,259,1978

oleandomycin price More Price(11)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 16552 Oleandomycin ≥95% 3922-90-5 5mg $121 2024-03-01 Buy
Cayman Chemical 16552 Oleandomycin ≥95% 3922-90-5 25mg $423 2024-03-01 Buy
Usbiological 257360 Oleandomycin 3922-90-5 1mg $744 2021-12-16 Buy
TRC O517500 Oleandomycin 3922-90-5 1mg $140 2021-12-16 Buy
TRC O517500 Oleandomycin 3922-90-5 2.5mg $305 2021-12-16 Buy
Product number Packaging Price Buy
16552 5mg $121 Buy
16552 25mg $423 Buy
257360 1mg $744 Buy
O517500 1mg $140 Buy
O517500 2.5mg $305 Buy

oleandomycin Chemical Properties,Uses,Production

Originator

Matromycin,Pfizer,US,1956

Uses

Oleandomycin is a 16-membered macrocyclic lactone, discovered in the 1950s, with broad spectrum antibacterial activity. Oleandomycin was developed as a human pharmaceutical but was regarded as less active than comparable products such as erythromycin and is today only available in combination with other antibiotics.

Uses

Antibiotic substance produced by Streptomyces antibioticus no. ATCC 11891. Antibacterial.

Definition

ChEBI: Oleandomycin is a member of oleandomycins. It is functionally related to an oleandolide. It is a conjugate base of an oleandomycin(1+).

Manufacturing Process

A slant of S. antibioticus ATCC 11891 was cultivated on agar under controlled conditions in order to develop spores for the purpose of inoculating a nutrient medium having the following composition: 20 g Cerelose (dextrose hydrate), 15 g soybean meal, 5 g distillers' solubles, 10 g cornmeal, and tap water, in a sufficient amount for a 1,000 ml solution, adjusted to pH 7.0 to 7.2 with potassium hydroxide.
After the pH was adjusted, 5 g of calcium carbonate was added. This inoculum medium was then subjected to heat sterilization. The medium was then cooled and 2 ml of a spore suspension of an oleandomycin-producing strain of S. antibioticus was added under aseptic conditions. The cultivation of the organism was conducted in shaken flasks at 28% for a period of 48 hours.
The mixture of broth and mycelium thus formed was then transferred under aseptic conditions to a 3-liter fermentor containing 2,000 ml of a sterile fermentation medium having the following composition: 60 g Cerelose (dextrose hydrate), 18 g soybean meal, 5 g distillers' solubles, 12 g cornmeal and tap water in a sufficient amount for a 1,000 ml total volume, adjusted to pH 7.0 to 7.2 with potassium hydroxide.
After the pH had been adjusted, 5 g of calcium carbonate, 5 ml of soybean oil antifoam and 0.020 g of Acridine Orange dye were added. The mixture was then autoclaved at 20 psi (250°F) for 15 minutes in order to sterilize the contents, before transferring the broth and mycelium thereto.
After seeding the nutrient medium with the preformed inoculum previously described, the mixture was subjected to agitation and aeration under aseptic conditions for 72 hours; at 27°C to 28°C for the first 24 hours, then at 25°C to 26°C for the next 48 hours; during this period, the pH was in the range of 6.4 to 6.8. Aeration was accomplished by cultivation under submerged conditions at an air flow rate of one volume of air per volume of medium per minute. After termination of the process, the mycelium was removed by filtration and the filtered broth found to contain 450 γ of oleandomycin per ml of solution.

brand name

Matromycin (Pfizer).

Therapeutic Function

Antibiotic

Pharmaceutical Applications

A natural 14-membered-ring macrolide produced by Streptomyces antibioticus. It is stable in acid conditions. It is less active than erythromycin A in vitro, but four times more active than spiramycin . Several attempts have been made to improve its potency by chemical modification while retaining its relative acid stability.
It is incompletely absorbed, but an ester, triacetyloleandomycin, gives improved plasma levels. Following doses of 0.5 g, mean peak serum levels around 0.8 mg/L were reached by the base and 2 mg/L by the triacetyl ester. A single oral dose of 1 g of the ester produced a mean plasma oleandomycin concentration of 4 mg/L at 1 h after dosing, with an AUC of 14 mg.h/L. The apparent elimination half-life was 4.2 h. Significant quantities of mostly inactivated compound are eliminated in the bile. About 10% of the dose appears in the urine after administration of the base and about 20% after the ester.
Nausea, vomiting and diarrhea are common. Like erythromycin estolate, triacetyloleandomycin can cause liver damage. Abnormal liver function tests were found in about one-third of patients treated for 2 weeks. Hepatic dysfunction resolved when treatment was discontinued. The action of drugs eliminated via the cytochrome P450 system may be potentiated.
Its uses are similar to those of erythromycin. It is of restricted availability.

Biological Activity

oleandomycin is an antibiotic produced by strains of streptomyces.

Safety Profile

A poison by intravenous route. Low toxicity by ingestion. When heated to decomposition it emits toxic vapors of NOx.

in vitro

oleandomycin has been identified as a macrolide antibiotic demonstrating antimicrobial activity similar to penicillin and erythromycin. in addition, oleandomycin structurally has a macrocyclic lactone ring of 14 carbon atoms with one sugar, oleandrose, and one amino sugar, desoxamine [1].

in vivo

the pk of oleandomycin after i.v. and po administration, both alone and after i.m. pretreatment with metamizole or dexamethasone, was studied in healthy dogs. results showed that after i.v. injection of oleandomycin alone at 10 mg/kg, the t1/2β, vd, cl and auc were 1.60 h, 1.11 l/kg, 7.36 ml/kg/min and 21.66 μg h/ml, respectively. there were no statistically significant differences following pretreatment with metamizole or dexamethasone. in addition, after po administration of oleandomycin alone, the t1/2β, cmax, tmax), mat and fabs were 1.68 h, 5.34 μg/ml, 1.5 h, 1.34 h and 84.29%, respectively, and the pretreatment with metamizole showed a significantly decreased value for cmax but the mat was increased significantly. statistically significant changes in the pk parameters of oleandomycin following po administration were also seen as a result of pretreatment with dexamethasone. the cmax was increased and the tmax and mat were lower [2].

References

[1] c. vilches, c. méndez, c. hardisson, et al. biosynthesis of oleandomycin by streptomyces antibioticus: influence of nutritional conditions and development of resistance. j.gen.microbiol. 136(8), 1447-1454 (1990).
[2] milanova a, lashev l. pharmacokinetics of oleandomycin in dogs after intravenous or oral administration alone and after pretreatment with metamizole or dexamethasone. vet res commun. 2002 jan;26(1):61-71.

oleandomycin Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 52)Suppliers
Supplier Tel Email Country ProdList Advantage
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
Fuxin Pharmaceutical
+86-021-021-50872116 +8613122107989 contact@fuxinpharm.com China 10297 58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
+86-021-61551413 +8618813727289 contact@trustwe.com China 5738 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Zhejiang Huida Biotech Co., LTD
008613515763466 8615669048680 wendy@huidabiotech.com CHINA 87 58
Alfa Chemistry
+1-5166625404 Info@alfa-chemistry.com United States 21317 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152 Mandy@hangyubiotech.com China 11013 58
Aladdin Scientific
+1-833-552-7181 sales@aladdinsci.com United States 52927 58
Chemsky(shanghai)International Co.,Ltd. 021-50135380 shchemsky@sina.com China 32344 50
C01946 8-(3,5-Dihydroxy-2,4-diMethylhexanoyl)-5-(4-diMethylaMinotetrahydro-3-hydroxy-6-Methylpyran-2-yloxy)-8,9-epoxy-2,4,6-triMethyl-3-(tetrahydro-5-hydroxy-4-Methoxy-6-Methylpyran-2-yloxy)nonanoic Acid μ-Lactone OleandoMycin A PA 775 AMiMycin, MatroMycin, PA 105 oleandomycin Oleandomycin (base and/or unspecified salts) Amimycin Antibiotic PA-105 Landomycin PA-105 Romicil 3922-90-5 C35H61NO12 C35H61NO11 Carbohydrates & Derivatives Chiral Reagents Intermediates & Fine Chemicals Pharmaceuticals